(ATE) Alten - Ratings and Ratios
Engineering Services, IT Services, R&D, Consulting
Description: ATE Alten
Alten SA is a global engineering and technology consultancy firm operating in multiple regions, including Europe, North America, and the Asia-Pacific. The company provides a wide range of services, including engineering, IT, and construction infrastructure services, to various industries such as aeronautics, automotive, energy, and finance.
With a diverse client base across multiple sectors, Alten SA has established itself as a significant player in the IT consulting and other services industry. The companys expertise spans various areas, including artificial intelligence, cybersecurity, data management, and software testing, making it a one-stop-shop for clients seeking technology and engineering solutions.
From a financial perspective, Alten SA has a market capitalization of approximately €2.684 billion, with a price-to-earnings ratio of 14.50 and a forward P/E of 11.96, indicating a relatively stable valuation. The companys return on equity (RoE) stands at 20.29%, suggesting a strong ability to generate profits from shareholder equity. Additionally, Alten SAs revenue growth and profit margins can be considered key performance indicators (KPIs) to evaluate its financial health.
Some other relevant KPIs for Alten SA could include its employee utilization rate, project win rate, and client satisfaction ratings, which can provide insights into the companys operational efficiency and competitiveness. Furthermore, the companys ability to adapt to emerging technologies and trends in the industry, such as digital transformation and sustainability, may also be crucial in driving its long-term growth and success.
ATE Stock Overview
| Market Cap in USD | 2,691m |
| Sub-Industry | IT Consulting & Other Services |
| IPO / Inception |
ATE Stock Ratings
| Growth Rating | -57.3% |
| Fundamental | 81.5% |
| Dividend Rating | 58.3% |
| Return 12m vs S&P 500 | -42.3% |
| Analyst Rating | - |
ATE Dividends
| Dividend Yield 12m | 2.11% |
| Yield on Cost 5y | 2.19% |
| Annual Growth 5y | 10.67% |
| Payout Consistency | 84.5% |
| Payout Ratio | 28.2% |
ATE Growth Ratios
| Growth Correlation 3m | -84.8% |
| Growth Correlation 12m | -65.9% |
| Growth Correlation 5y | -22.6% |
| CAGR 5y | -14.35% |
| CAGR/Max DD 3y | -0.24 |
| CAGR/Mean DD 3y | -0.62 |
| Sharpe Ratio 12m | -0.43 |
| Alpha | 0.06 |
| Beta | 0.752 |
| Volatility | 28.15% |
| Current Volume | 50.2k |
| Average Volume 20d | 30.3k |
| Stop Loss | 63.4 (-3.1%) |
| Signal | 0.19 |
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income (419.6m TTM) > 0 and > 6% of Revenue (6% = 492.7m TTM) |
| FCFTA 0.17 (>2.0%) and ΔFCFTA 11.28pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 7.44% (prev 19.73%; Δ -12.29pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.18 (>3.0%) and CFO 671.3m > Net Income 419.6m (YES >=105%, WARN >=100%) |
| Net Debt (82.8m) to EBITDA (845.6m) ratio: 0.10 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.52 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (34.9m) change vs 12m ago NaN% (target <= -2.0% for YES) |
| Gross Margin 16.50% (prev 10.67%; Δ 5.83pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 232.8% (prev 110.9%; Δ 121.9pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 35.67 (EBITDA TTM 845.6m / Interest Expense TTM 19.5m) >= 6 (WARN >= 3) |
Altman Z'' 4.17
| (A) 0.17 = (Total Current Assets 1.78b - Total Current Liabilities 1.17b) / Total Assets 3.64b |
| (B) 0.05 = Retained Earnings (Balance) 186.4m / Total Assets 3.64b |
| (C) 0.20 = EBIT TTM 695.6m / Avg Total Assets 3.53b |
| (D) 1.50 = Book Value of Equity 2.15b / Total Liabilities 1.43b |
| Total Rating: 4.17 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 81.46
| 1. Piotroski 7.50pt = 2.50 |
| 2. FCF Yield 26.18% = 5.0 |
| 3. FCF Margin 7.74% = 1.93 |
| 4. Debt/Equity 0.19 = 2.48 |
| 5. Debt/Ebitda 0.50 = 2.31 |
| 6. ROIC - WACC (= 13.92)% = 12.50 |
| 7. RoE 20.29% = 1.69 |
| 8. Rev. Trend 63.53% = 4.77 |
| 9. EPS Trend -34.45% = -1.72 |
What is the price of ATE shares?
Over the past week, the price has changed by +0.31%, over one month by -3.47%, over three months by -9.29% and over the past year by -31.44%.
Is Alten a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ATE is around 56.62 EUR . This means that ATE is currently overvalued and has a potential downside of -13.49%.
Is ATE a buy, sell or hold?
What are the forecasts/targets for the ATE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 97.5 | 49% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 62.7 | -4.2% |
ATE Fundamental Data Overview
Market Cap EUR = 2.29b (2.29b EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = 288.1m EUR (Cash And Short Term Investments, last quarter)
P/E Trailing = 12.3026
P/E Forward = 9.1158
P/S = 0.5539
P/B = 1.0261
Beta = 1.296
Revenue TTM = 8.21b EUR
EBIT TTM = 695.6m EUR
EBITDA TTM = 845.6m EUR
Long Term Debt = 259.9m EUR (from nonCurrentLiabilitiesTotal, last quarter)
Short Term Debt = 161.2m EUR (from shortTermDebt, last quarter)
Debt = 421.2m EUR (Calculated: Short Term 161.2m + Long Term 259.9m)
Net Debt = 82.8m EUR (from netDebt column, last quarter)
Enterprise Value = 2.43b EUR (2.29b + Debt 421.2m - CCE 288.1m)
Interest Coverage Ratio = 35.67 (Ebit TTM 695.6m / Interest Expense TTM 19.5m)
FCF Yield = 26.18% (FCF TTM 635.5m / Enterprise Value 2.43b)
FCF Margin = 7.74% (FCF TTM 635.5m / Revenue TTM 8.21b)
Net Margin = 5.11% (Net Income TTM 419.6m / Revenue TTM 8.21b)
Gross Margin = 16.50% ((Revenue TTM 8.21b - Cost of Revenue TTM 6.86b) / Revenue TTM)
Tobins Q-Ratio = 1.13 (Enterprise Value 2.43b / Book Value Of Equity 2.15b)
Interest Expense / Debt = 2.03% (Interest Expense 8.57m / Debt 421.2m)
Taxrate = 33.51% (94.0m / 280.4m)
NOPAT = 462.5m (EBIT 695.6m * (1 - 33.51%))
Current Ratio = 1.52 (Total Current Assets 1.78b / Total Current Liabilities 1.17b)
Debt / Equity = 0.19 (Debt 421.2m / last Quarter total Stockholder Equity 2.21b)
Debt / EBITDA = 0.50 (Net Debt 82.8m / EBITDA 845.6m)
Debt / FCF = 0.66 (Debt 421.2m / FCF TTM 635.5m)
Total Stockholder Equity = 2.07b (last 4 quarters mean)
RoA = 11.52% (Net Income 419.6m, Total Assets 3.64b )
RoE = 20.29% (Net Income TTM 419.6m / Total Stockholder Equity 2.07b)
RoCE = 29.88% (Ebit 695.6m / (Equity 2.07b + L.T.Debt 259.9m))
RoIC = 21.56% (NOPAT 462.5m / Invested Capital 2.14b)
WACC = 7.64% (E(2.29b)/V(2.72b) * Re(8.79%)) + (D(421.2m)/V(2.72b) * Rd(2.03%) * (1-Tc(0.34)))
Shares Correlation 3-Years: 68.70 | Cagr: 0.21%
Discount Rate = 8.79% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 76.27% ; FCFE base≈465.4m ; Y1≈485.4m ; Y5≈560.1m
Fair Price DCF = 246.4 (DCF Value 8.57b / Shares Outstanding 34.8m; 5y FCF grow 4.55% → 3.0% )
EPS Correlation: -34.45 | EPS CAGR: -23.21% | SUE: 4.0 | # QB: 1
Revenue Correlation: 63.53 | Revenue CAGR: 3.99% | SUE: N/A | # QB: None